ArticleNature communications2025
Rapid endothelialization of printed vascular grafts by perivascular niche-circulating endothelial progenitors crosstalk.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Perivascular administration of metformin through 3D minichannels improved adventitia ingrowth and endothelialization for electrospinning vascular grafts.Bioactive materials · 2026Article
- Exploring Perivascular Adipose Tissue Responses to Bioresorbable Thermoplastic Polyurethane Vascular Grafts.Biomaterials research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
Successful regeneration of small-diameter vascular grafts requires rapid endothelialization to ensure patency. However, effectively recruiting circulating endothelial progenitor cells to achieve this remains a significant challenge. Here we show that accelerating the growth of adventitia into vascular grafts promotes fallout endothelialization on the blood-contacting surface. We engineered Micro-Nano structured Vascular Grafts (MnVGs) using high-resolution electrohydrodynamic (EHD) printing and electrostatic spinning. When implanted in rabbits, MnVGs rapidly regenerated neo-adventitia within the highly porous graft walls and achieved endothelialization as early as 2 weeks postoperatively, resulting in 90% patency rate (18/20). The regenerated arteries closely matched native vessels in structure and function. Mechanistically, we discovered that lymphatic endothelial cells enriched in the neoadventitia, were identified as the main contributors to the early recruitment of CD93+ ECs, which ultimately constituted the majority of the endothelium. Thus, MnVGs represent a potential strategy to preventing thrombosis in replacement of small caliber arteries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.